3

PRIMARY DOCUMENT

Company: SELLAS Life Sciences Group, Inc.
Filed: October 27, 2011
Period of Report: October 17, 2011
Accession Number: 0001250853-11-000078

View Document ↗ View on SEC.gov ↗